Product Information
LOSARTAN POTASSIUM 50 MG TAB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0327 per EA under NDC 68180037709. Its NADAC has been published 401 times since Jan 30, 2019.
FDA first approved this application on Oct 6, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180037709
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LOSARTAN POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA078232FDA Approved
10/6/2010
TE Code
AB
On Market Since
11/1/2017
Pharmacological Classes
Price Statistics
The NADAC for LOSARTAN POTASSIUM 50 MG TAB has been published 401 times since Jan 30, 2019, and over the history we have for it it has declined 8.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0327 per EA |
|---|---|
| All-time high | $0.1233 (Sep 16, 2020) |
| All-time low | $0.0304 (Nov 19, 2025) |
| 52-week high | $0.0343 |
| 52-week low | $0.0304 |
| Median price | $0.0457 |
| Average price | $0.0585 |
| Largest weekly change | +29.7% (Aug 21, 2019) |
| Weeks tracked | 401 |
| Tracking since | Jan 30, 2019 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Losartan Potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOSARTAN POTASSIUM 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LOSARTAN POTASSIUM 50 MG TAB, manufactured by Lupin Pharmaceuticals Inc., is $0.0327 per EA (NDC 68180037709), effective Sep 30, 2026.
How has the price of LOSARTAN POTASSIUM 50 MG TAB changed over time?
Over the history we have for it, the NADAC for LOSARTAN POTASSIUM 50 MG TAB has declined 8.2%. It has been tracked across 401 weekly CMS publications since Jan 30, 2019.
What are the highest and lowest recorded NADAC prices for LOSARTAN POTASSIUM 50 MG TAB?
Since Jan 30, 2019, the NADAC for LOSARTAN POTASSIUM 50 MG TAB has ranged from a low of $0.0304 (Nov 19, 2025) to a high of $0.1233 (Sep 16, 2020), with a median of $0.0457 per EA.
Are there cheaper alternatives to LOSARTAN POTASSIUM 50 MG TAB?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOSARTAN POTASSIUM 50 MG TAB, is $0.0315 per EA — about 4% below LOSARTAN POTASSIUM 50 MG TAB.
Who manufactures LOSARTAN POTASSIUM 50 MG TAB?
LOSARTAN POTASSIUM 50 MG TAB (NDC 68180037709) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.